Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial

Rob, L., Mallmann, P., Knapp, P., Melichar, B., Klat, J., Minář, L., Novotný, Z., Bartůňková, J., Spíšek, R., Pecen, L., Bin Hassan, H. I., Cibula, D. Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial. Journal of Clinical Oncology. 2018, 36(15 S), 5509. ISSN 0732-183X. E-ISSN 1527-7755. Dostupné z: doi: 10.1200/JCO.2018.36.15_suppl.5509